Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference109 articles.
1. Goldman JM, Melo JV . Chronic myeloid leukemia – advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451–1464.
2. Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965–1971.
3. Lydon NB, Druker BJ . Lessons learned from the development of imatinib. Leukemia Res 2004; 28S1: S29–S38.
4. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ et al. Abl protein kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139–145.
5. Okuda K, Weisberg E, Gilliland DG, Griffen JD . ARG tyrosine kinase activity is inhibited by STI571. Blood 2001; 97: 2440–2448.
Cited by
275 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献